Paloma Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Paloma Partners’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-135,953	Closed	-$428K	–	2500
2020 Q3	$428K	Buy	+135,953	New	+$434K	0.01%	1269
2020 Q1	–	Sell	-16,983	Closed	-$55K	–	2411
2019 Q4	$55K	Sell	16,983 -169,917	-91%	-$493K	﹤0.01%	2078
2019 Q3	$404K	Sell	186,900 -14,347	-7%	-$38.3K	0.01%	1326
2019 Q2	$632K	Buy	+201,247	New	+$653K	0.01%	917
2019 Q1	–	Sell	-48,600	Closed	-$141K	–	2112
2018 Q4	$141K	Sell	48,600 -155,300	-76%	-$427K	﹤0.01%	1095
2018 Q3	$536K	Buy	+203,900	New	+$500K	0.01%	1002
2018 Q2	–	Sell	-19,068	Closed	-$56K	–	2489
2018 Q1	$56K	Sell	19,068 -59,326	-76%	-$162K	﹤0.01%	1855
2017 Q4	$215K	Buy	78,394 +47,239	+152%	+$145K	﹤0.01%	1704
2017 Q3	$106K	Buy	31,155 +255	+0.8%	+$709	﹤0.01%	2031
2017 Q2	$76K	Buy	+30,900	New	+$71.1K	﹤0.01%	2092
2016 Q2	–	Sell	-79,533	Closed	-$265K	–	2502
2016 Q1	$265K	Buy	+79,533	New	+$248K	﹤0.01%	1583
2013 Q4	–	Sell	-22,900	Closed	-$183K	–	1373
2013 Q3	$183K	Sell	22,900 -1,296	-5%	-$10.4K	0.01%	761
2013 Q2	$187K	Buy	+24,196	New	+$189K	0.01%	954

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Paloma Partners's PDLI Position: Q4 2020 in Review

Paloma Partners sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 135,953 shares — an estimated $428K sold.

Paloma Partners first reported a position in PDLI in Q2 2013 and held it in 13 quarters. The position peaked at $632K in Q2 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

Paloma Partners reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 135,953 PDL BioPharma, Inc. shares in Q4 2020, an estimated $428K.
Paloma Partners first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 13 quarters.
Paloma Partners's PDL BioPharma, Inc. position peaked at $632K in Q2 2019.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.